Extranodal NK-T-cell lymphoma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Extranodal NK-T-cell lymphoma}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==Refer...")
 
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Extranodal NK-T-cell lymphoma}}
{{Extranodal NK-T-cell lymphoma}}
 
{{CMG}}; {{AE}} {{AS}}
Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
==Overview==
Patients of all age groups may develop extranodal NK-T-cell lymphoma. Males are more commonly affected with extranodal NK-T-cell lymphoma than females. The majority of extranodal NK-T-cell lymphoma cases are reported in Asian, Central-American, and South–American countries.
==Epidemiology and Demographics==
===Age===
Patients of all age groups may develop extranodal NK-T-cell lymphoma.
===Gender===
Males are more commonly affected with extranodal NK-T-cell lymphoma than females.
===Race===
The majority of extranodal NK-T-cell lymphoma cases are reported in Asian, Central-American, and South–American countries.


==References==
==References==
{{reflist|2}}
{{reflist|2}}
[[Category:Needs content]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Types of cancer]]
[[Category:Types of cancer]]

Revision as of 15:03, 3 February 2016

Extranodal NK-T-cell lymphoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Extranodal NK-T-cell lymphoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Xray

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Extranodal NK-T-cell lymphoma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Extranodal NK-T-cell lymphoma epidemiology and demographics

CDC on Extranodal NK-T-cell lymphoma epidemiology and demographics

Extranodal NK-T-cell lymphoma epidemiology and demographics in the news

Blogs on Extranodal NK-T-cell lymphoma epidemiology and demographics

Risk calculators and risk factors for Extranodal NK-T-cell lymphoma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Patients of all age groups may develop extranodal NK-T-cell lymphoma. Males are more commonly affected with extranodal NK-T-cell lymphoma than females. The majority of extranodal NK-T-cell lymphoma cases are reported in Asian, Central-American, and South–American countries.

Epidemiology and Demographics

Age

Patients of all age groups may develop extranodal NK-T-cell lymphoma.

Gender

Males are more commonly affected with extranodal NK-T-cell lymphoma than females.

Race

The majority of extranodal NK-T-cell lymphoma cases are reported in Asian, Central-American, and South–American countries.

References


Template:WikiDoc Sources